"Project 3" Defining the in vivo function of ncRNAs during MHV68 latency and lymphomagenesis

“项目 3”定义 ncRNA 在 MHV68 潜伏期和淋巴瘤发生过程中的体内功能

基本信息

  • 批准号:
    10403017
  • 负责人:
  • 金额:
    $ 30.02万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-02-09 至 2027-01-31
  • 项目状态:
    未结题

项目摘要

Project Summary The transforming human gammaherpesviruses EBV and KSHV establish stable latent infections in B cells, providing a lifelong reservoir of virus that can contribute to the development of malignant disease. Thus, defining the mechanisms that govern long-term latency and tumorigenesis is critical for designing rational strategies to prevent disease. In vivo studies of gammaherpesviruses in humans have been severely limited by the difficulties of working in the natural host. Murine gammaherpesvirus 68 (MHV68) is related to EBV and KSHV and causes lymphomas and lymphoproliferative disease in mice, providing a readily manipulatable small animal model for mechanistic studies of the virus/host relationship in vivo. Like EBV and KSHV, MHV68 expresses multiple forms of ncRNAs whose functions during infection and pathogenesis are largely unknown. In contrast to most gammaherpesvirus protein-coding genes, gammaherpesvirus ncRNAs are abundantly expressed in vivo during chronic infection and in hyperplastic lesions during lymphoproliferative disease, suggesting that these ncRNAs may play key conserved roles in latency and tumorigenesis. In support of this, we have demonstrated that MHV68 TMER4 and EBV EBER1 share a conserved function in hematogenous dissemination, and that in vivo suppression of a conserved miRNA target promotes B cell latency. Further, our new preliminary findings implicate both small ncRNAs and miRNAs in the genesis and progression of virus-induced B cell lymphoma. Thus, we hypothesize that gammaherpesviruses utilize a broad array of ncRNAs to shape critical B cell signaling pathways and thereby promote virus dissemination, latency and tumorigenesis. In Aim 1 (in collaboration with Project 2 and with support from Cores C and D), we will define the mechanisms by which gammaherpesvirus small RNAs promote the egress and dissemination of infected B cells, facilitate B cell latency at peripheral sites, and drive key stages of lymphomagenesis. In Aim 2 (in collaboration with Projects 2 and 3, and with support from Cores B, C and D) we will define the contribution of gammaherpesvirus miRNA repression of host mRNAs and lncRNAs to B cell latency and lymphomagenesis. The highly collaborative nature of this program, along with the systematic in vivo analyses of ncRNA mutants and recombinant viruses carrying EBV or KSHV genes, provides an extremely powerful means to determine the specific molecular mechanisms by which ncRNAs contribute to gammaherpesvirus latency and tumorigenesis.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Scott A. Tibbetts其他文献

Scott A. Tibbetts的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Scott A. Tibbetts', 18)}}的其他基金

"Project 3" Defining the in vivo function of ncRNAs during MHV68 latency and lymphomagenesis
“项目 3”定义 ncRNA 在 MHV68 潜伏期和淋巴瘤发生过程中的体内功能
  • 批准号:
    10865790
  • 财政年份:
    2023
  • 资助金额:
    $ 30.02万
  • 项目类别:
Gammaherpesvirus miRNA suppression of EWSR1 in GC B cell infection and lymphomagenesis
伽马疱疹病毒 miRNA 对 GC B 细胞感染和淋巴瘤发生中 EWSR1 的抑制
  • 批准号:
    10276889
  • 财政年份:
    2021
  • 资助金额:
    $ 30.02万
  • 项目类别:
Gammaherpesvirus miRNA suppression of EWSR1 in GC B cell infection and lymphomagenesis
伽马疱疹病毒 miRNA 对 GC B 细胞感染和淋巴瘤发生中 EWSR1 的抑制
  • 批准号:
    10458112
  • 财政年份:
    2021
  • 资助金额:
    $ 30.02万
  • 项目类别:
Gammaherpesvirus miRNA suppression of EWSR1 in GC B cell infection and lymphomagenesis
伽马疱疹病毒 miRNA 对 GC B 细胞感染和淋巴瘤发生中 EWSR1 的抑制
  • 批准号:
    10665619
  • 财政年份:
    2021
  • 资助金额:
    $ 30.02万
  • 项目类别:
"Core D" Clinical Sample and Tumorigenesis Core
“Core D”临床样本和肿瘤发生核心
  • 批准号:
    10646260
  • 财政年份:
    2017
  • 资助金额:
    $ 30.02万
  • 项目类别:
"Core D" Clinical Sample and Tumorigenesis Core
“Core D”临床样本和肿瘤发生核心
  • 批准号:
    10403021
  • 财政年份:
    2017
  • 资助金额:
    $ 30.02万
  • 项目类别:
"Project 3" Defining the in vivo function of ncRNAs during MHV68 latency and lymphomagenesis
“项目 3”定义 ncRNA 在 MHV68 潜伏期和淋巴瘤发生过程中的体内功能
  • 批准号:
    10646240
  • 财政年份:
    2017
  • 资助金额:
    $ 30.02万
  • 项目类别:
Role of MHV68 miRNAs in latencyand pathogenesis
MHV68 miRNA 在潜伏期和发病机制中的作用
  • 批准号:
    8846933
  • 财政年份:
    2015
  • 资助金额:
    $ 30.02万
  • 项目类别:
Role of MHV68 miRNAs in latencyand pathogenesis
MHV68 miRNA 在潜伏期和发病机制中的作用
  • 批准号:
    9195696
  • 财政年份:
    2015
  • 资助金额:
    $ 30.02万
  • 项目类别:
LSUHSC COBRE: DEFINING BONE MARROW AS A RESERVOIR FOR GAMMAHERPESVIRUS LATENCY
LSUHSC COBRE:将骨髓定义为伽玛疱疹病毒潜伏期的储库
  • 批准号:
    8359692
  • 财政年份:
    2011
  • 资助金额:
    $ 30.02万
  • 项目类别:

相似海外基金

Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
  • 批准号:
    495434
  • 财政年份:
    2023
  • 资助金额:
    $ 30.02万
  • 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
  • 批准号:
    10642519
  • 财政年份:
    2023
  • 资助金额:
    $ 30.02万
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    $ 30.02万
  • 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
  • 批准号:
    10590479
  • 财政年份:
    2023
  • 资助金额:
    $ 30.02万
  • 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
  • 批准号:
    23K06011
  • 财政年份:
    2023
  • 资助金额:
    $ 30.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
  • 批准号:
    10682117
  • 财政年份:
    2023
  • 资助金额:
    $ 30.02万
  • 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
  • 批准号:
    10708517
  • 财政年份:
    2023
  • 资助金额:
    $ 30.02万
  • 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
  • 批准号:
    10575566
  • 财政年份:
    2023
  • 资助金额:
    $ 30.02万
  • 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
  • 批准号:
    23K15696
  • 财政年份:
    2023
  • 资助金额:
    $ 30.02万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
  • 批准号:
    23K15867
  • 财政年份:
    2023
  • 资助金额:
    $ 30.02万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了